Establishment of endoradiotherapy for adenoid cystic carcinomaand analysis of potential resistance mechanisms

Recruiting

• Conditions: C07; Submandibular gland; Sublingual gland; C08.0; C08.1; Major salivary gland, unspecified; C08.9; Malignant neoplasm of parotid gland

• Registration Number: DRKS00032205
• Lead Sponsor: niversitätsklinikum Heidelberg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

As part of the planned study, patients with ACC in the head and neck area who are undergoing therapy at Heidelberg University Hospital are to be included after the study protocol has been checked and the ethics committee has given its approval. Patients with initial diagnosis or recurrence are included. In addition, patients with a benign disease of the salivary glands are to be included as a control group. These are initially selected at random and an adjustment in the final evaluation is intended to ensure comparability of both groups (benign vs. malignant).

Exclusion Criteria

Pre-existing mental illnesses, minors, patients who are not fully legally capable of giving consent, patients whose consent to the use of samples or data for an experimental study has been revoked.

Study & Design

• Study Type: observational
• Study Design: Not specified